A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

Conditions

• Vascular Access Device

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Not accepted

Interventions

• Central venous catheter — DEVICE
  Placement of a medical device to gain entry into the bloodstream, typically through a vein or artery, for the purpose of administering fluids, medications, blood products, or for hemodialysis

Study Details

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting

Key Dates

Start date

Dec 8, 2024

Status verified

Sep 2024

Primary completion

Dec 7, 2034

Completion

Dec 7, 2034

Study Design

Enrollment

2,500 participants (estimated)

Arms

• Arm: Subject
  Needing a vascular access device for therapy or diagnosis

Primary Outcome Measure

Catheter devices: successful use of the device without removal due to device-related adverse events [ Time Frame: Within 7 days after subject device removal ]

Central Contacts

• Aderinola (Derin) Ogundimu, PhD, ACRP, PMP
  469.569.9223
  [email protected]
• Thomas E. Philbeck, Jr., PhD
  2107227438
  [email protected]

Locations (3)

Find similar trials in Huntsville, AL